Cite
MLA Citation
A.P. Fernandez et al.. “Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5‐year data from reSURFACE 1 and reSURFACE 2.” Journal of the European Academy of Dermatology and Venereology, vol. 36, 2022, pp. 1774–1783. http://access.bl.uk/ark:/81055/vdc_100163729330.0x000045